Subscribe
roschetzkyistockphoto
roschetzky / iStockphoto
5 March 2019Americas

‘Breaking’ patents would harm innovation: think tank

The Information Technology and Innovation Foundation (ITIF) think tank has called on the US National Institutions of Health (NIH) to maintain IP protection amid calls to “break” patents in order to lower drug prices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank
23 June 2021   Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.
Americas
Gilead claims US government PrEP patents are invalid
20 May 2019   Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.
Big Pharma
US patent reforms could re-establish gene patent eligibility, industry experts warn
6 June 2019   A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Biotechnology
Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank
23 June 2021   Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.
Americas
Gilead claims US government PrEP patents are invalid
20 May 2019   Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.
Big Pharma
US patent reforms could re-establish gene patent eligibility, industry experts warn
6 June 2019   A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

More on this story

Biotechnology
Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank
23 June 2021   Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.
Americas
Gilead claims US government PrEP patents are invalid
20 May 2019   Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.
Big Pharma
US patent reforms could re-establish gene patent eligibility, industry experts warn
6 June 2019   A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility